Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | |
| Sales | 18,796 | 20,067 |
| Gross Profit | 18,796 | 20,067 |
| Operating Expenses | 39,557 | 37,886 |
| Operating Income | -20,761 | -17,819 |
| Interest Expense | 0 | 88 |
| Other Income | 148 | 101 |
| Pre-tax Income | -20,613 | -17,806 |
| Net Income Continuous | -20,613 | -17,806 |
| Net Income | $-20,613 | $-17,806 |
| EPS Basic Total Ops | -21.14 | -19.54 |
| EPS Basic Continuous Ops | -21.14 | -19.55 |
| EPS Diluted Total Ops | -21.14 | -19.54 |
| EPS Diluted Continuous Ops | -21.14 | -19.55 |
| EPS Diluted Before Non-Recurring Items | -0.94 | N/A |
| EBITDA(a) | $-19,826 | $-16,777 |